← Leaderboards
S Ananth Karumanchi
Cedars-Sinai Medical Center
$6,503,001
Attributed
$7,393,669
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $720.5K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,393,669 · 10
By mechanism
R01$5,595,563 · 4
R21$1,006,280 · 3
K08$616,626 · 1
R03$170,000 · 1
R13$5,200 · 1
Top collaborators
- Ravi Thadhani4 shared
Most similar at Cedars-Sinai Medical Center
Same institution · by research overlap
- Dmitriy Sheyn$3,287,510
Others in their field
Top investigators on “Proteinuria”
- Sumant Singh Chugh · Rush University Medical Center$16,742,378
- Susan L Furth · Johns Hopkins University$14,867,927
- Bradley Alan Warady · Children'S Mercy Hosp (Kansas City, Mo)$14,607,267
- Andrzej S Krolewski · Joslin Diabetes Center$12,693,842
- Martin R. Pollak · Beth Israel Deaconess Medical Center$12,517,502
- Stuart Johnston Knechtle · University Of Wisconsin Madison$11,789,092
Research focus
ProteinuriaWomanHypertensionPathogenesisPlacentaPregnancyPhenotypeVascular Endothelial Growth Factor Receptor-1Pre-EclampsiaFetalVascular Endothelial Growth FactorsResearch PersonnelNovel TherapeuticsLeadBlood CirculationEtiologyAngiogenic ProteinsRodentKidneyPlacentationPlayBiologyPathway InteractionsIschemia
Grant awards (28)
Placental Organoids to Model Preeclampsia$417,500
R01 · FY2025 · HL · contact PI
Impaired Renal Reserve and Preeclampsia$208,750
R21 · FY2025 · HD · contact PI
Placental Organoids to Model Preeclampsia$417,500
R01 · FY2024 · HL · contact PI
Impaired Renal Reserve and Preeclampsia$250,500
R21 · FY2024 · HD · contact PI
Placental Organoids to Model Preeclampsia$417,500
R01 · FY2023 · HL · contact PI
Placental Organoids for Modeling and Treating Preeclampsia$49,030
R21 · FY2022 · HD · contact PI
Redefining Vitamin D Deficiency: The Role of Bioavailable Vitamin D$440,709
R01 · FY2018 · DK
Redefining Vitamin D Deficiency: The Role of Bioavailable Vitamin D$440,709
R01 · FY2017 · DK
Role of ADAMTS13 in Maternal Complications of Preeclampsia$218,250
R21 · FY2017 · HD · contact PI
Redefining Vitamin D Deficiency: The Role of Bioavailable Vitamin D$440,709
R01 · FY2016 · DK
Role of ADAMTS13 in Maternal Complications of Preeclampsia$279,750
R21 · FY2016 · HD · contact PI
Redefining Vitamin D Deficiency: The Role of Bioavailable Vitamin D$459,209
R01 · FY2015 · DK
2012 Endothelial Cell Phenotypes in Health & Disease GRC/GRS$5,200
R13 · FY2012 · HL · contact PI
Angiogenesis-related gene products in preeclampsia$205,443
R01 · FY2008 · HL · contact PI
Role of VEGF in Glomerular Endothelial Health & Diseases$333,254
R01 · FY2007 · DK · contact PI
Angiogenesis-related gene products in preeclampsia$322,381
R01 · FY2007 · HL · contact PI
Role of VEGF in Glomerular Endothelial Health & Diseases$343,207
R01 · FY2006 · DK · contact PI
Angiogenesis-related gene products in preeclampsia$332,010
R01 · FY2006 · HL · contact PI
Role of VEGF in Glomerular Endothelial Health &Diseases$351,466
R01 · FY2005 · DK
Angiogenesis-related gene products in preeclampsia$322,500
R01 · FY2005 · HL
Role of VEGF in Glomerular Endothelial Health &Diseases$351,466
R01 · FY2004 · DK
ROLE OF TGF BETA 1 IN RENAL CANCER$124,929
K08 · FY2004 · DK
Placental Gene Expression Profile in Preeclampsia$85,000
R03 · FY2004 · DK
ROLE OF TGF BETA 1 IN RENAL CANCER$124,929
K08 · FY2003 · DK
Placental Gene Expression Profile in Preeclampsia$85,000
R03 · FY2003 · DK
ROLE OF TGF BETA 1 IN RENAL CANCER$126,009
K08 · FY2002 · DK
ROLE OF TGF BETA 1 IN RENAL CANCER$119,529
K08 · FY2001 · DK
ROLE OF TGF BETA 1 IN RENAL CANCER$121,230
K08 · FY2000 · DK